Pneumococcal Disease
📧 Sign up to get email alerts when something new happens for Pneumococcal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants. [Phase 3]
Phase 3 trial evaluating a 13-valent pneumococcal conjugate vaccine in infants has completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants [Phase 3]
This Phase 3 trial evaluated a 13-valent pneumococcal conjugate vaccine in infants; the study is completed and results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants [Phase 3]
Wyeth (now Pfizer) completed a Phase 3 trial evaluating a 13-valent pneumococcal conjugate vaccine in infants, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants [Phase 3]
This entry reports the completion of a Phase 3 study evaluating a 13-valent pneumococcal conjugate vaccine in infants and the posting of res…
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants [Phase 3]
Phase 3 trial evaluating a 13-valent pneumococcal conjugate vaccine in infants was completed, with results posted in 2012 after Wyeth became…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants [Phase 3]
Phase 3 clinical trial update on the 13-valent pneumococcal conjugate vaccine in healthy Japanese infants; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants. [Phase 3]
A Phase 3 trial evaluating a 13-valent pneumococcal conjugate vaccine in infants has completed, with results posted in 2012. The study spons…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: The Study of Chest Infections in Infants Living in a Refugee Camp on the Thai-Burmese Border
A completed clinical trial studied chest infections in infants living in a refugee camp on the Thai-Burmese border, focusing on childhood pn…
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults [Phase 2]
Phase 2 trial evaluating the immunogenicity and reactogenicity of a pneumococcal conjugate vaccine in healthy adults has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan
Pfizer-sponsored trial update reporting on the disease burden of pneumococcal disease (pneumonia, meningitis, and bacteremia) among children…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers [Phase 4]
Phase 4 trial updating antibody response in healthy Chinese children previously vaccinated with Prevenar as infants, assessing long-term imm…
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children. [Phase 3]
Phase 3 study evaluating the impact of the 13-valent pneumococcal conjugate vaccine in Alaskan Native children; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose. [Phase 3]
A Phase 3 trial evaluated the antibody response to the 13-valent pneumococcal conjugate vaccine (PCV13) 24 months after the toddler dose; re…
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: Study Evaluating Prevnar Infant Long-term Immune Response Versus Prevnar Naive Cohort [Phase 2]
Phase 2 trial evaluating the long-term immune response to Prevnar in infants, comparing previously vaccinated infants to a Prevnar-naive coh…
-
CLINICAL_TRIALS trial_result · 2011-10-10Clinical Trial Update: Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup [Phase 3]
Phase 3 update reporting completion of a second extension study evaluating safety, tolerability, immunogenicity, and co-administration of in…
-
CLINICAL_TRIALS trial_result · 2011-07-18Clinical Trial Update: Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Children [Phase 3]
A Phase 3 trial evaluating the 13-valent pneumococcal conjugate vaccine in healthy children has completed and results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan [Phase 3]
Phase 3 trial evaluating a 13-valent pneumococcal conjugate vaccine in infants in Taiwan has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS [Phase 3]
Phase 3 trial evaluating the safety, tolerability, and immunogenicity of the 13-valent pneumococcal conjugate vaccine (PCV13) given as a two…
-
CLINICAL_TRIALS trial_result · 2011-03-22Clinical Trial Update: 13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study [Phase 4]
A Phase 4 follow-on study of the 13-valent pneumococcal conjugate vaccine has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico [Phase 3]
A Phase 3 trial evaluating the 13-valent pneumococcal conjugate vaccine in healthy infants in Mexico has completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects [Phase 3]
A Phase 3 trial evaluating a 13-valent pneumococcal conjugate vaccine in elderly adults completed and posted results in 2011.
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: Generation of Standard Laboratory Values for Pneumococci Antibodies
A completed clinical trial update reporting the generation of standard laboratory reference values for pneumococcal antibodies.
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea [Phase 2]
Phase 2 trial evaluating a 13-valent pneumococcal conjugate vaccine in infants in Korea has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil [Phase 3]
Phase 3 study evaluating the 13-valent pneumococcal conjugate vaccine in healthy Brazilian infants has completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2010-08-05Clinical Trial Update: Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects [Phase 2]
A Phase 2 clinical trial evaluating a 13-valent pneumococcal conjugate vaccine in elderly subjects has completed.